Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 606


Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.

Zeng X, Zhang Y, Yang L, Xu H, Zhang T, An R, Zhu K.

Medicine (Baltimore). 2018 Jun;97(26):e11251. doi: 10.1097/MD.0000000000011251. Review.


RAD51 135G>C polymorphism and risk of sporadic colorectal cancer in Iranian population.

Yazdanpanahi N, Salehi R, Kamali S.

J Cancer Res Ther. 2018 Apr-Jun;14(3):614-618. doi: 10.4103/0973-1482.183558.


Defects in recombination activity caused by somatic and germline mutations in the multimerization/BRCA2 binding region of human RAD51 protein.

Silva MC, Bryan KE, Morrical MD, Averill AM, Dragon J, Wiegmans AP, Morrical SW.

DNA Repair (Amst). 2017 Dec;60:64-76. doi: 10.1016/j.dnarep.2017.10.008. Epub 2017 Oct 23.


A cell-penetrating antibody inhibits human RAD51 via direct binding.

Turchick A, Hegan DC, Jensen RB, Glazer PM.

Nucleic Acids Res. 2017 Nov 16;45(20):11782-11799. doi: 10.1093/nar/gkx871.


Fanconi-Anemia-Associated Mutations Destabilize RAD51 Filaments and Impair Replication Fork Protection.

Zadorozhny K, Sannino V, Beláň O, Mlčoušková J, Špírek M, Costanzo V, Krejčí L.

Cell Rep. 2017 Oct 10;21(2):333-340. doi: 10.1016/j.celrep.2017.09.062.


RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.

King HO, Brend T, Payne HL, Wright A, Ward TA, Patel K, Egnuni T, Stead LF, Patel A, Wurdak H, Short SC.

Stem Cell Reports. 2017 Jan 10;8(1):125-139. doi: 10.1016/j.stemcr.2016.12.005.


Cryo-EM structures of human RAD51 recombinase filaments during catalysis of DNA-strand exchange.

Xu J, Zhao L, Xu Y, Zhao W, Sung P, Wang HW.

Nat Struct Mol Biol. 2017 Jan;24(1):40-46. doi: 10.1038/nsmb.3336. Epub 2016 Dec 12.


Dynamic unwrapping of nucleosomes by HsRAD51 that includes sliding and rotational motion of histone octamers.

Senavirathne G, Mahto SK, Hanne J, O'Brian D, Fishel R.

Nucleic Acids Res. 2017 Jan 25;45(2):685-698. doi: 10.1093/nar/gkw920. Epub 2016 Oct 13.


Tyrosine phosphorylation stimulates activity of human RAD51 recombinase through altered nucleoprotein filament dynamics.

Subramanyam S, Ismail M, Bhattacharya I, Spies M.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6045-E6054. Epub 2016 Sep 26.


(-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer.

Yang Q, Wu J, Luo Y, Huang N, Zhen N, Zhou Y, Sun F, Li Z, Pan Q, Li Y.

Oncotarget. 2016 Sep 20;7(38):62585-62597. doi: 10.18632/oncotarget.11540.


A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.

Balbous A, Cortes U, Guilloteau K, Rivet P, Pinel B, Duchesne M, Godet J, Boissonnade O, Wager M, Bensadoun RJ, Chomel JC, Karayan-Tapon L.

BMC Cancer. 2016 Aug 5;16:604. doi: 10.1186/s12885-016-2647-9.


Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.

Alshareeda AT, Negm OH, Aleskandarany MA, Green AR, Nolan C, TigHhe PJ, Madhusudan S, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2016 Aug;159(1):41-53. doi: 10.1007/s10549-016-3915-8. Epub 2016 Jul 27.


Oleandrin induces DNA damage responses in cancer cells by suppressing the expression of Rad51.

Bao Z, Tian B, Wang X, Feng H, Liang Y, Chen Z, Li W, Shen H, Ying S.

Oncotarget. 2016 Sep 13;7(37):59572-59579. doi: 10.18632/oncotarget.10726.


135G/C polymorphism in the RAD51 gene and acute myeloid leukemia risk: a meta-analysis.

Wu L, Long ZG, Dai ZS.

Genet Mol Res. 2016 Apr 4;15(2). doi: 10.4238/gmr.15027383.


Increased expression of SET domain-containing proteins and decreased expression of Rad51 in different classes of renal cell carcinoma.

Liu S, Li Y, Xu H, Wang K, Li N, Li J, Sun T, Xu Y.

Biosci Rep. 2016 Jun 30;36(3). pii: e00349. doi: 10.1042/BSR20160122. Print 2016 Jul.


RAD51 variant proteins from human lung and kidney tumors exhibit DNA strand exchange defects.

Silva MC, Morrical MD, Bryan KE, Averill AM, Dragon J, Bond JP, Morrical SW.

DNA Repair (Amst). 2016 Jun;42:44-55. doi: 10.1016/j.dnarep.2016.02.008. Epub 2016 Apr 25.


Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair.

Shao J, Xu Z, Peng X, Chen M, Zhu Y, Xu L, Zhu H, Yang B, Luo P, He Q.

PLoS One. 2016 Jan 11;11(1):e0146968. doi: 10.1371/journal.pone.0146968. eCollection 2016.


Homozygous T172T and Heterozygous G135C Variants of Homologous Recombination Repairing Protein RAD51 are Related to Sporadic Breast Cancer Susceptibility.

Al-Zoubi MS, Mazzanti CM, Zavaglia K, Al Hamad M, Armogida I, Lisanti MP, Bevilacqua G.

Biochem Genet. 2016 Feb;54(1):83-94. doi: 10.1007/s10528-015-9703-z. Epub 2015 Dec 9.


Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population.

Mucha B, Kabzinski J, Dziki A, Przybylowska-Sygut K, Sygut A, Majsterek I, Dziki L.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11601-7. eCollection 2015.


Association between RAD 51 rs1801320 and susceptibility to glioblastoma.

Franceschi S, Tomei S, Mazzanti CM, Lessi F, Aretini P, La Ferla M, De Gregorio V, Pasqualetti F, Zavaglia K, Bevilacqua G, Naccarato AG.

J Neurooncol. 2016 Jan;126(2):265-70. doi: 10.1007/s11060-015-1974-z. Epub 2015 Oct 28.


Supplemental Content

Support Center